Mark Duncan, MD

Personal Statement

I have pursued a career at the intersection of mental health and primary care, training in both family medicine and addiction psychiatry.  I currently practice in various integrated care settings as a consulting psychiatrist and in the outpatient adult psychiatry clinic.  I am the co-medical director for the University of Washington Psychiatry and Addiction Case Conference (UW PACC), a weekly online learning collaborative to help community providers across the state improve their psychiatric and addiction clinical skills.  My area of interest is focused on improving addiction and psychiatric treatment to primary care settings.  I also spend a significant amount of time training both family medicine and psychiatry trainees and fellows on integrated treatments for substance use disorders.

Education

Rush University Medical education, 2006
West Suburban Medical Center Residency, Family Medicine
University of Washington - School of Medicine Residency, Psychiatry
University of Washington - School of Medicine Fellowship, Addiction Psychiatry

Department Affiliations

Substance use treatment integration in primary care settings; substance use in underserved populations.​

Recent Publications

Extended-release Naltrexone Is Not Linked to Hepatotoxicity in Adults Experiencing Homelessness and Alcohol Use Disorder.
(2023 May-Jun 01)
J Addict Med 17(3): 363-366
Vutien P, Kim NJ, Merrill JO, Duncan MH, Ioannou GN, Collins SE

Extended-release Naltrexone Is Not Linked to Hepatotoxicity in Adults Experiencing Homelessness and Alcohol Use Disorder.
(2023 Jan 6)
J Addict Med
Vutien P, Kim NJ, Merrill JO, Duncan MH, Ioannou GN, Collins SE

Psychiatry's Expanded Integration into Primary Care.
(2022 Mar)
Psychiatr Clin North Am 45(1): 71-80
Duncan MH, Erickson JM, Chang D, Toor R, Ratzliff ADH

Development and Implementation of an Integrated Care Fellowship.
(2022 May-Jun)
J Acad Consult Liaison Psychiatry 63(3): 280-289
Ratzliff ADH, Toor R, Erickson JM, Bauer AM, Duncan MH, Chang D, Chwastiak L, Raue PJ, Unutzer J

Dual study describing patient-driven harm reduction goal-setting among people experiencing homelessness and alcohol use disorder.
(2021 Jun)
Exp Clin Psychopharmacol 29(3): 261-271
Fentress TSP, Wald S, Brah A, Leemon G, Reyes R, Alkhamees F, Kramer M, Taylor EM, Wildhood M, Frohe T, Duncan MH, Clifasefi SL, Collins SE

Show complete publication list »
Edit Profile